Psoriasis treatment and biologic switching: The association with clinical characteristics and laboratory biomarkers over a 13-year retrospective study.

J Dermatol · 2024 · PMC11624150 · PMID 39269210

Europe PMC DOI

hedged sentence

0.0880

closest p · 1.8× alpha

0.0880

boldest claim

The sentences

showed a trendp = 0.088so close (0.05 < p ≤ 0.1)

IL‐23i showed a trend towards shorter drug survival compared with IL‐17i ( p = 0.088) but was not statistically significant. 4 DISCUSSION In 2017, Honda et al. reported that one‐sixth of patients with psoriasis and arthritis from a cohort of 51 individuals, experienced a switch in biologic therapy. 18 Since 2015, bi

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.